Goltz, D., Gevensleben, H., Dietrich, J., & Dietrich, D. (2016). PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients. Oncoimmunology.
Citación estilo ChicagoGoltz, Diane, Heidrun Gevensleben, Jörn Dietrich, y Dimo Dietrich. "PD-L1 (CD274) Promoter Methylation Predicts Survival in Colorectal Cancer Patients." Oncoimmunology 2016.
Cita MLAGoltz, Diane, Heidrun Gevensleben, Jörn Dietrich, y Dimo Dietrich. "PD-L1 (CD274) Promoter Methylation Predicts Survival in Colorectal Cancer Patients." Oncoimmunology 2016.
Precaución: Estas citas no son 100% exactas.